Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-011 + FOLFOX in Metastatic Colorectal Cancer
NCT00890305Phase 2Completed
- Sponsor
- Medivation
- Start
- May 2009
- Primary completion
- May 2012
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of pidilizumab in metastatic colorectal cancer (mCRC), sponsored by Medivation. Started May 2009; status: completed.
02
Drugs
pidilizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00890305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890305.